Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer

PaperCitations, authors & open-access status

Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 829 citations, 2018 year and gold oa status.

829
Citations
2018
Year
gold
OA Status

Related on ScholarIQ

Shang‐Gin Wu
Author
Jin‐Yuan Shih
Author
Lung Cancer Treatments and Mutations
Topic
Lung Cancer Treatments and Mutations
Topic
Lung Cancer Research Studies
Topic
Cancer Genomics and Diagnostics
Topic
470M+ articles · free account